Evolent Health (EVH) director receives 41,096 restricted stock units award

Rhea-AI Filing Summary

Evolent Health, Inc. director Jill D. Smith reported an equity compensation grant. She acquired 41,096 shares of Class A Common Stock in the form of restricted stock units granted under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

The securities vest on the earlier of June 4, 2027 or the company’s 2027 annual meeting, contingent on her continued service through the vesting date. Following this award, Smith holds 64,233 shares of Evolent Health common stock directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Smith Jill D.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	41,096	$0.00	--

Holdings After Transaction: Class A Common Stock — 64,233 shares (Direct, null)

Footnotes (1)

1. Represents restricted stock units granted to Ms. Smith pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.

Key Figures

RSU grant size: 41,096 shares Shares after transaction: 64,233 shares Vesting date: June 4, 2027 +2 more

5 metrics

RSU grant size 41,096 shares Restricted stock units granted to director Jill D. Smith

Shares after transaction 64,233 shares Total direct holdings following award

Vesting date June 4, 2027 Earlier of this date or 2027 annual meeting

Transaction code A (Grant, award, or other acquisition) Indicates equity compensation grant, not market trade

Reported price per share $0.00 Compensation award, no cash paid by insider

Key Terms

restricted stock units, Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan, vest, Class A Common Stock

4 terms

restricted stock units financial

"Represents restricted stock units granted to Ms. Smith pursuant to the Amended"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan financial

"granted to Ms. Smith pursuant to the Amended and Restated Evolent Health, Inc."

vest financial

"Securities vest on the earlier of June 4, 2027, and the date of the Company's"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Class A Common Stock financial

"security_title": "Class A Common Stock""

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith Jill D.

(Last) (First) (Middle)

C/O EVOLENT HEALTH, INC.

1812 N. MOORE ST., STE. 1705

(Street)

ARLINGTON VIRGINIA 22209

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Evolent Health, Inc. [ EVH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock(1)	06/04/2026		A		41,096(2)	A	$0	64,233	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units granted to Ms. Smith pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

2. Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.

Remarks:

	/s/ Jonathan Weinberg, Attorney-in-fact	06/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Evolent Health (EVH) disclose for Jill D. Smith?

Evolent Health director Jill D. Smith received a grant of 41,096 restricted stock units as equity compensation. These units represent Class A Common Stock and increase her direct holdings to 64,233 shares after the award.

How many Evolent Health (EVH) shares did Jill D. Smith acquire in this Form 4?

Jill D. Smith acquired 41,096 shares of Class A Common Stock in the form of restricted stock units. The grant was reported at a price of $0.00 per share, indicating a compensation award rather than a market purchase.

When do Jill D. Smith’s new Evolent Health (EVH) restricted stock units vest?

The restricted stock units vest on the earlier of June 4, 2027, or the date of Evolent Health’s 2027 annual meeting. Vesting is conditioned on Jill D. Smith’s continued service with the company through the applicable vesting date.

What is Jill D. Smith’s total Evolent Health (EVH) shareholding after this grant?

After the reported grant, Jill D. Smith directly holds 64,233 shares of Evolent Health Class A Common Stock. This total includes the newly awarded 41,096 restricted stock units reported in this Form 4 filing.

Under which plan were Jill D. Smith’s Evolent Health (EVH) restricted stock units granted?

The restricted stock units were granted under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. This plan is used by the company to deliver stock-based compensation to directors and other eligible participants.

Was Jill D. Smith’s Evolent Health (EVH) Form 4 transaction a market purchase or sale?

The transaction was not a market trade. It was reported with code “A” as a grant or award acquisition, reflecting restricted stock units granted as compensation at a reported price of $0.00 per share rather than an open-market transaction.